Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Analysis of Compound HeterozygousCYP2C19Genotypes to DetermineCisandTransConfigurations
Skierka, Jennifer M., Black, John L.

Pharmacogenomics | August 21, 2014 | Volume: 15 | Issue: 9 | Pages: 1197-1205

10.2217/pgs.14.72 | PMID 25141895 Get It

Klebsiella pneumoniae ST147 Coproducing NDM-7 Carbapenemase and RmtF 16S rRNA Methyltransferase in Minnesota
Lee, Chang‐Seop , Vasoo, Shawn , Patel, Robin , Doi, Yohei , Hu, Fupin , Patel, Robin , Doi, Yohei

Journal of Clinical Microbiology | August 21, 2014 | Volume: 52 | Issue: 11 | Pages: 4109-4110

10.1128/jcm.01404-14 | PMID 25143576 Get It

Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Detected by 11 C-Choline Positron Emission Tomography/Computerized Tomography
Karnes, R. Jeffrey , Bergstralh, Eric J., Dimonte, Guy , Cheville, John C. , Lowe, Val J. , Mynderse, Lance A. , Kwon, Eugene D., Murphy, Christopher R, Murphy, Christopher Raymond

Journal of Urology | August 20, 2014 | Volume: 193 | Issue: 1 | Pages: 111-116

10.1016/j.juro.2014.08.082 | PMID 25150640 Get It

Bone disease in hypoparathyroidism
Clarke, B.L. , Clarke, Bart L

Arquivos Brasileiros de Endocrinologia & Metabologia | August 20, 2014 | Volume: 58 | Issue: 5 | Pages: 545-552

10.1590/0004-2730000003399 | PMID 25166046 Get It

Hypoparathyroidism is a rare disorder that may be acquired or inherited. Postsurgical hypoparathyroidism is responsible for the majority of acquired hypoparathyroidism. Bone disease occurs in hypoparathyroidism due to markedly reduced bone remodeling due to the absence or low levels of parathyroid hormone. Chronically reduced bone turnover in patients with hypoparathyroidism typically leads to higher bone mass than in age- and sex-matched controls. Whether this increased bone density reduces fracture risk is less certain, because while increased bone mineralization may be associated with increased brittleness of bone, this does not appear to be the case in hypoparathyroidism. Treatment of hypoparathyroidism with recombinant parathyroid hormone may reduce bone mineral density but simultaneously strengthen the mechanical properties of bone.
Emerging trends in hepatocellular carcinoma incidence and mortality
Njei, Basile , Rotman, Yaron , Ditah, Ivo, Lim, Joseph K., Rotman, Yaron

Hepatology | August 20, 2014 | Volume: 61 | Issue: 1 | Pages: 191-199

10.1002/hep.27388 | PMID 25142309 Get It

The rise in incidence of hepatocellular carcinoma (HCC) in the United States has been well documented. The purpose of this analysis was to examine temporal trends in HCC incidence, mortality, and survival within the U.S. population. The Surveillance, Epidemiology, and End Results data were used to examine incidence and incidence‐based (IB) mortality in HCC from 1973 to 2011. Secular trends in age‐adjusted incidence and IB mortality by sex and cancer stage were characterized using the Joinpoint Regression program. In 1973, HCC incidence was 1.51 cases per 100,000, whereas in 2011, HCC incidence was 6.20 cases per 100,000. Although HCC incidence continues to increase, a slowing of the rate of increase occurs around 2006. In a sensitivity analysis, there was no significant increase in incidence and IB mortality from 2009 to 2011. There was a significant increase in overall median survival from the 1970s to 2000s (2 vs. 8 months; P < 0.001). On multivariable Cox's regression analysis, age, sex, race, tumor grade, stage at diagnosis, lymph/vascular invasion, number of primary tumors, tumor size, and liver transplant were independently associated with mortality. Conclusion: Our results indicate a deceleration in the incidence of HCC around 2006. Since 2009 and for the first time in four decades, there is no increase in IB mortality and incidence rates for HCC in the U.S. population. The nonsignificant increase in incidence and IB mortality in recent years suggest that the peak of the HCC epidemic may be near. A significant survival improvement in HCC was also noted from 1973 to 2010, which seems to be driven by earlier detection of HCC at a curative stage and greater utilization of curative modalities (especially transplant). (Hepatology 2015;61:191–199)
Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces
Simonetto, Douglas A. , Yang, Hui‐yin, Yin, Meng , Assuncao, Thiago M. de , Kwon, Jung Hee, Hilscher, Moira , Pan, Shuchong, Yang, Liu , Bi, Yan , Cao, Sheng , Simari, Robert D., Kamath, Patrick S. , Shah, Vijay H. , Yang, Hui-yin, Beyder, Arthur , Ehman, Richard L. , Yin, Meng , Simonetto, Douglas A , Yang, Liu

Hepatology | August 20, 2014 | Volume: 61 | Issue: 2 | Pages: 648-659

10.1002/hep.27387 | PMID 25142214 Get It

Chronic passive hepatic congestion (congestive hepatopathy) leads to hepatic fibrosis; however, the mechanisms involved in this process are not well understood. We developed a murine experimental model of congestive hepatopathy through partial ligation of the inferior vena cava (pIVCL). C57BL/6 and transgenic mice overexpressing tissue factor pathway inhibitor (SM22α‐TFPI) were subjected to pIVCL or sham. Liver and blood samples were collected and analyzed in immunohistochemical, morphometric, real‐time polymerase chain reaction, and western blot assays. Hepatic fibrosis and portal pressure were significantly increased after pIVCL concurrent with hepatic stellate cell (HSC) activation. Liver stiffness, as assessed by magnetic resonance elastography, correlated with portal pressure and preceded fibrosis in our model. Hepatic sinusoidal thrombosis as evidenced by fibrin deposition was demonstrated both in mice after pIVCL as well as in humans with congestive hepatopathy. Warfarin treatment and TFPI overexpression both had a protective effect on fibrosis development and HSC activation after pIVCL. In vitro studies show that congestion stimulates HSC fibronectin (FN) fibril assembly through direct effects of thrombi as well as by virtue of mechanical strain. Pretreatment with either Mab13 or Cytochalasin‐D, to inhibit β‐integrin or actin polymerization, respectively, significantly reduced fibrin and stretch‐induced FN fibril assembly. Conclusion : Chronic hepatic congestion leads to sinusoidal thrombosis and strain, which in turn promote hepatic fibrosis. These studies mechanistically link congestive hepatopathy to hepatic fibrosis. (H epatology 2015;61:648‐659)
Another atrial septal occluder?
Hagler, Donald J.

Catheterization and Cardiovascular Interventions | August 20, 2014 | Volume: 84 | Issue: 3 | Pages: 471-472

10.1002/ccd.25607 | PMID 25142427 Get It

The Role of Jet Eccentricity in Generating Disproportionately Elevated Transaortic Pressure Gradients in Patients with Aortic Stenosis
Abbas, Amr E. , Franey, Laura M., Lester, Steven J., Raff, Gilbert , Gallagher, Michael J. , Hanzel, George , Safian, Robert D. , Pîbarot, Philippe , Pibarot, Phillippe

Echocardiography | August 20, 2014 | Volume: 32 | Issue: 2 | Pages: 372-382

10.1111/echo.12712 | PMID 25138664 Get It

In patients with aortic stenosis (AS) and eccentric transaortic flow, greater pressure loss occurs as the jet collides with the aortic wall together with delayed and diminished pressure recovery. This leads to the elevated transaortic valve pressure gradients noted on both Doppler and cardiac catheterization. Such situations may present a diagnostic dilemma where traditional measures of stenosis severity indicate severe AS, while imaging modalities of the aortic valve geometric aortic valve area (GOA) suggest less than severe stenosis. In this study, we present a series of cases exemplifying this clinical dilemma and demonstrate how color M‐mode, 2D and 3D transthoracic (TTE) and transesophageal (TEE) echocardiography, cardiac computed tomography angiography (CTA), and magnetic resonance imaging (MRI), may be used to resolve such discrepancies.
Targeting TRP Channels For Novel Migraine Therapeutics
Yan, Jin , Xie, Jennifer Y. , Ossipov, Michael H. , Dussor, Gregory O. , Dodick, David W. , Porreca, Frank

ACS Chemical Neuroscience | August 20, 2014 | Volume: 5 | Issue: 11 | Pages: 1085-1096

10.1021/cn500083e | PMID 25138211 Get It

Abstract Migraine is increasingly understood to be a disorder of the brain. In susceptible individuals, a variety of ?triggers? may influence altered central excitability, resulting in the activation and sensitization of trigeminal nociceptive afferents surrounding blood vessels (i.e., the trigeminovascular system), leading to migraine pain. Transient receptor potential (TRP) channels are expressed in a subset of dural afferents, including those containing calcitonin gene related peptide (CGRP). Activation of TRP channels promotes excitation of nociceptive afferent fibers and potentially lead to pain. In addition to pain, allodynia to mechanical and cold stimuli can result from sensitization of both peripheral afferents and of central pain pathways. TRP channels respond to a variety of endogenous conditions including chemical mediators and low pH. These channels can be activated by exogenous stimuli including a wide range of chemical and environmental irritants, some of which have been demonstrated to trigger migraine in humans. Activation of TRP channels can elicit CGRP release, and blocking the effects of CGRP through receptor antagonism or antibody strategies has been demonstrated to be effective in the treatment of migraine. Identification of approaches that can prevent activation of TRP channels provides an additional novel strategy for discovery of migraine therapeutics.
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice
Jung, Jaehoon , Kim, Hwajin , Heo, Rok Won, Yi, Chin‐ok, Jeon, Byeong Tak, Kim, Won–Ho , Hahm, Jong Ryeal , Kim, Seok Chan , Lee, Jung Eun , Roh, Gu Seob

The Korean Journal of Physiology & Pharmacology | August 20, 2014 | Volume: 18 | Issue: 4 | Pages: 333

10.4196/kjpp.2014.18.4.333 | PMID 25177166 Get It